LumiThera's key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on ...

Investing.com - STAAR Surgical Company (NASDAQ:STAA)向Alcon AG (NYSE:ALC)的有争议的出售案在其最大股东采取正式步骤发起代理权争夺以阻止每股28美元的合并后进一步升级。

(Nasdaq:STAA) announced today that it filed a definitive proxy statement related to its planned merger with Alcon.

Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with ...

In addition to the proxy statement, STAAR has reached out to all stockholders to ask for their vote to adopt the merger ...

Investing.com - Stifel将STAAR Surgical (NASDAQ: STAA )的评级从买入下调至持有，同时将目标价从20.00美元上调至28.00美元，此举是在Alcon宣布收购该公司后做出的。过去一周，STAAR股价已上涨超过50%， InvestingPro 数据显示该股目前处于超买区域。

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it has filed its ...

Investing.com - STAAR Surgical Company (NASDAQ:STAA)与Alcon AG (NYSE:ALC)之间有争议的出售交易升级，该公司最大股东正式采取第一步行动，发起代理权争夺战以阻止每股28美元的合并交易。

Alcon (NYSE: ALC) shares registered just barely in the plus column Tuesday. The company, purporting to be the global leader in eye care dedicated to helping people see brilliantly, announced results ...

Part of Alcon's motivations for continuing to pursue the lawsuit relates to an upcoming TV series based on the movie. The company expressed that it wants to distance itself from Tesla and Elon Musk.